Phenazopyridine

Generic Name
Phenazopyridine
Brand Names
Phenazo, Pyridium, Uristat, Urobiotic
Drug Type
Small Molecule
Chemical Formula
C11H11N5
CAS Number
94-78-0
Unique Ingredient Identifier
K2J09EMJ52
Background

Phenazopyridine, also known as Pyridium, is a urinary tract analgesic used for the short-term management of urinary tract irritation and its associated unpleasant symptoms such as burning and pain during urination. In the USA, this drug was previously marked by Roche but has been discontinued by the FDA. It is still used in various parts of the world. Ingest...

Indication

Phenazopyridine hydrochloride is indicated to relieve uncomfortable symptoms that occur as a consequence of mucosal irritation of the lower urinary tract in adults. The irritation may be a result of trauma, surgery, endoscopic procedures, infection, or the insertion of instruments or urinary catheters. Phenazopyridine may be used in combination with antimicr...

Associated Conditions
Lower Urinary Tract Infection, Signs or symptoms of urinary tract irritation
Associated Therapies
-
Clinical Trials
Related News

Prophylactic Analgesia for Bladder Botox Injections

First Posted Date
2024-07-23
Last Posted Date
2024-11-12
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
120
Registration Number
NCT06514430
Locations
🇺🇸

Montefiore Medical Center Female Pelvic Medicine Reconstructive Surgery Department, Bronx, New York, United States

Oral vs Intravesical Analgesia for Office Bladder Botox Injections

First Posted Date
2018-11-27
Last Posted Date
2020-05-29
Lead Sponsor
Women and Infants Hospital of Rhode Island
Target Recruit Count
110
Registration Number
NCT03755089
Locations
🇺🇸

Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States

Investigating Oral Agents for Urine Staining to Facilitate Intraoperative Observation of Ureteral Jets

Early Phase 1
Completed
Conditions
Ureteral Injury
Interventions
Drug: Thiamine
Drug: Riboflavin
Drug: Pyridium
First Posted Date
2018-02-14
Last Posted Date
2020-08-11
Lead Sponsor
Texas Tech University Health Sciences Center
Target Recruit Count
120
Registration Number
NCT03432572
Locations
🇺🇸

Texas Tech University Health Sciences Center, Lubbock, Texas, United States

Assessing Pyridium for Post-Sling Urinary Retention

Phase 4
Completed
Conditions
Urinary Retention
Interventions
Drug: Phenazopyridine
First Posted Date
2017-10-05
Last Posted Date
2019-10-29
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
98
Registration Number
NCT03302936
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Effect of Phenazopyridine on Prolapse Surgery Voiding Trials

Phase 3
Completed
Conditions
Urinary Retention Postoperative
Interventions
Drug: Phenazopyridine
First Posted Date
2017-02-27
Last Posted Date
2019-04-16
Lead Sponsor
University of Massachusetts, Worcester
Target Recruit Count
152
Registration Number
NCT03065075
Locations
🇺🇸

University of Massachusetts, Worcester, Massachusetts, United States

The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)

First Posted Date
2016-06-21
Last Posted Date
2019-02-05
Lead Sponsor
University of Massachusetts, Worcester
Target Recruit Count
92
Registration Number
NCT02806713
Locations
🇺🇸

Umass Memorial, Worcester, Massachusetts, United States

Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

Not Applicable
Withdrawn
Conditions
Ureteral Injury
Interventions
Drug: sodium fluorescein
Drug: phenazopyridine
First Posted Date
2016-05-02
Last Posted Date
2022-05-06
Lead Sponsor
University Hospitals Cleveland Medical Center
Registration Number
NCT02757417
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Using Phenazopyridine for In-office Cystoscopy

Not Applicable
Conditions
Cystoscopy
Phenazopyridine
Interventions
Drug: Phenazopyridine
First Posted Date
2016-03-22
Last Posted Date
2020-12-31
Lead Sponsor
Boston Urogynecology Associates
Target Recruit Count
94
Registration Number
NCT02715648
Locations
🇺🇸

Boston Urogynecology Associates, 725 Concord Ave. Suite 1200, Cambridge, Massachusetts, United States

Evaluation of Fluorescein Use During Cystoscopy

Not Applicable
Withdrawn
Conditions
Intraoperative Cystoscopy
Interventions
Drug: Fluorescein
Drug: Phenazopyridine
First Posted Date
2016-03-09
Last Posted Date
2018-01-12
Lead Sponsor
Johns Hopkins University
Registration Number
NCT02703558

Evaluation of Ureteral Patency in the Post-indigo Carmine Era

First Posted Date
2016-02-09
Last Posted Date
2019-05-30
Lead Sponsor
Columbia University
Target Recruit Count
140
Registration Number
NCT02677623
Locations
🇺🇸

Columbia University Medical Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy